Bloomberg
Glaxo CEO Walmsley on Tech Partnerships, Tesaro Acquisition, Pricing
Jan.13 -- Emma Walmsley, chief executive officer at GlaxoSmithKline Plc, discusses new tech partnerships, the acquisition of drugmaker Tesaro, and efforts to increase transparency in drug pricing. She speaks with Bloomberg's Taylor Riggs...
Bloomberg
Bill Ackman: Venezuela Could Kill Herbalife's Earnings
Oct. 13 -- Bill Ackman, chief executive officer at Pershing Square Holdings Ltd., discusses the latest developments in the joint pursuit of Allergan with Valeant Pharmaceuticals and how Herbalife results may suffer from the currency...
Bloomberg
Reshaping the Pharma Industry
June 28 -- Jami Rubin, partner at Goldman Sachs, discusses the impact of Brexit on the pharmaceutical industry, research and development in the sector and companies she's keeping an eye on. She speaks to Bloomberg's Joe Weisenthal, Matt...
Bloomberg
Psychedelic Drugs Are Fueling a Mental Health Revolution
Nov.23 -- Once deemed dangerous and illegal, psychedelic compounds have been rediscovered by the scientific, medical and psychiatric communities as research reveals their capacity to help patients with a range of maladies. With investors...
Bloomberg
Trump: Get Drug Prices Down, Streamline FDA Approvals
Jan.31 -- President Donald Trump talks of the need to reduce drug prices, while streamlining the FDA approval process for new medicines, and bringing drug makers back to the United States. Trump speaks before a White House meeting with...
Bloomberg
Sanofi CFO Says 2017 the Toughest Year on Diabetes
Apr.28 -- April 28 (Bloomberg) –- Jerome Contamine, chief financial officer at Sanofi, discusses the company's diabetes activity with Guy Johnson on "Bloomberg Markets: European Open."
Bloomberg
Amazon Expands Health Care Push With Online Pharmacy
Nov.17 -- Amazon.com Inc. is launching a digital pharmacy and offering discounts on medicines to paying Prime members in the U.S. Bloomberg’s Drew Armstrong reports on “Bloomberg Surveillance.”
Bloomberg
Midterm Issues: Minimum Wage, Soda Tax, Marijuana
Nov. 5 -- On Before The Bell, Robert Nardelli, former chief executive officer at Chrysler, and Bloomberg's Betty Liu and Matt Miller run down the top stories of the day. They speak on In The Loop.
Bloomberg
Chinas Dengue Fight Sees Hope in Sanofi Vaccine
Oct. 8 -- Bloomberg Intelligences Sam Fazeli discusses Chinas fight to contain an outbreak of Dengue fever, as six people have succumbed to the virus and efforts by Sanofi to develop a Dengue vaccine. He speaks on The Pulse.
Bloomberg
Growth Entirely Driven by New Products, Says Roche CEO
Oct.17 -- Severin Schwan, chief executive officer at Roche, discusses 3Q results, new medicines, the stock price, competition from biosimilars, drug pricing in the U.S., his outlook for doing business in China and the impact of the trade...
Bloomberg
Teva, Others in Talks With DOJ to End Generic Drug Probe
Nov.25 -- Teva Pharmaceuticals Industries Ltd. and other generic drugmakers have held talks with the U.S. Justice Department about resolving a criminal anti-trust probe of alleged price fixing by the companies. Bloomberg’s Kailey Leinz...
Bloomberg
The Consumer Is Biggest Disrupter in Healthcare, Says JPMorgan's Gill
Jan.07 -- Lisa Gill, managing director and senior equity analyst at JPMorgan, discusses how the consumer is going to be disruptive in health care this year, specialty drugs, M&A in 2019, the CVS-Aetna Merger, her thoughts on Walgreens...
Bloomberg
CVS Shares Slump as Omnicare Deal Hits 2019 Forecast
Feb.20 -- CVS Health Corp. warned on 2019 results as the company takes a $2.2 billion writedown on its 2015 takeover of pharmacy company Omnicare. Bloomberg's David Wilson reports on "Bloomberg Markets."
Bloomberg
Trump Treated With Mix of Drugs and Experimental Antibody Cocktail
Oct.05 -- President Donald Trump has been treated for Covid-19 with a mix of well known and experimental medicines while at Walter Reed Medical Center. He's been given remdesivir, an antiviral drug made by Gilead. He's also taken the...
Bloomberg
Valeant Gets Default Notice From Creditors
April 13 -- Less than a week after getting a waiver from its most senior lenders Valeant Pharmaceuticals International Inc. is now facing pressure from its bondholders to file its delayed financials. Valeant said Tuesday it received a...
Bloomberg
Bayer Plans Stock Listing for Material-Science Unit
Sept. 18 -- Bayer AG plans to list its plastics unit on the stock market, accelerating its retreat from the chemicals industry after 151 years to focus on more lucrative life-sciences businesses.Bayer CEO Marijn Dekkers speaks on In The...
Bloomberg
Investors Are Missing Out on Opportunities in Health Care, Glenview's Robbins Says
Oct.28 -- Larry Robbins, Glenview Capital Management founder and chief executive officer, discusses his work with the Robin Hood Foundation and investment opportunities in health care with Bloomberg's Vonnie Quinn on "Bloomberg Markets:...
Bloomberg
Alice Rivlin Sees a Sensible Agreement on Obamacare
Jan.25 -- Alice Rivlin, senior fellow at Brookings Institution, discusses the future of Obamacare under President Donald Trump. She speaks with Bloomberg's David Westin on "Bloomberg Daybreak: Americas."
Bloomberg
Carl Icahn Exerts Pressure on Cigna-Express Deal
Aug.03 -- Billionaire activist Carl Icahn's influence on Cigna Corp.'s takeover bid of Express Scripts Holding Co., was felt, but not heard on Cigna's second-quarter call with analysts. Bloomberg Opinion's Brooke Sutherland reports on...
Bloomberg
Bayer Will Donate Chloroquine If Drug Can Treat Virus, CEO Says
Apr.27 -- Bayer AG raised the specter of “considerable liquidity challenges” as it engages in high-stakes negotiations in the U.S. over claims that the company's Roundup weedkiller caused cancer. Chief Executive Officer Werner Baumann...
Bloomberg
Stock Exchange: Top Asia Equities Movers
April 12 -- In today's "Stock Exchange," Bloomberg's Shery Ahn, David Ingles and Haidi Lun discuss the top three stocks to watch in Asia on "First Up."
Bloomberg
Is the U.S. Government Ready for an Ebola Outbreak?
Sept. 24 -- Bloomberg's Brendan Greeley discusses Ebola and how unprepared the U.S. government is for a potential outbreak. He speaks on Market Makers. (Source: Bloomberg)
Bloomberg
J&J CFO Says 3Q Earnings Beat Driven by Actelion Deal
Oct.17 -- Dominic Caruso, chief financial officer at Johnson & Johnson, discusses third-quarter results and the company’s strategic review of its diabetes products. He speaks with Bloomberg's David Westin on "Bloomberg Daybreak: Americas."